ABSTRACT The functional roles of the two nucleotide binding folds, NBF1 and NBF2, in the activation of the cystic fibrosis transmembrane conductance regulator (CFTR) were investigated by measuring the rates of activation and deactivation of CFTR CI-conductance in Xenopus oocytes. Activation of wild-type CFTR in response to application of forskolin and 3-isobutyl-l-methylxanthine (IBMX) was described by a single exponential. Deactivation after washout of the cocktail consisted of two phases: an initial slow phase, described by a latency, and an exponential decline. Rate analysis of CFTR variants bearing analogous mutations in NBF1 and NBF2 permitted us to characterize amino acid substitutions according to their effects on the accessibility and stability of the active state. Access to the active state was very sensitive to substitutions for the invariant glycine (G551) in NBF1, where mutations to alanine (A), serine (S), or aspartic acid (D) reduced the apparent on rate by more than tenfold. The analogous substitutions in NBF2 (G1349) also reduced the on rate, by twofold to 10-fold, but substantially destabilized the active state as well, as judged by increased deactivation rates. In the putative ATP-binding pocket of either NBF, substitution of alanine, glutamine (Q), or arginine (R) for the invariant lysine (K464 or K1250) reduced the on rate similarly, by two-to fourfold. In contrast, these analogous substitutions produced opposite effects on the deactivation rate. NBF1 mutations destabilized the active state, whereas the analogous substitutions in NBF2 stabilized the active state such that activation was prolonged compared with that seen with wild-type CFTR. Substitution of asparagine (N) for a highly conserved aspartic acid (D572) in the ATP-binding pocket of NBF1 dramatically slowed the on rate and destabilized the active state. In contrast, the analogous substitution in NBF2 (D1370N) did not appreciably affect the on rate and markedly stabilized the active state. These results are consistent with a hypothesis for CFTR activation that invokes the binding and hydrolysis of ATP at NBF1 as a crucial step in activation, while at NBF2, ATP binding enhances access to the active state, but the rate of ATP hydrolysis controls the duration of the active state. The relatively slow time courses for activation and deactivation suggest that slow processes modulate ATP-dependent gating.
INTRODUCTION
The cystic fibrosis transmembrane conductance regulator (CFTR) is a membrane protein that functions as a Cl--selective ion channel (Anderson et al., 1991b; Bear et al., 1992) . Analysis of the primary amino acid sequence of CFTR (Riordan et al., 1989) provided evidence for three cytosolic domains that are likely to be involved in the regulation of CFTR function: the R domain, which contains multiple consensus sites for phos-phorylation by cAMP-dependent protein kinase (PKA), and two nucleotide binding folds (NBF1 and NBF2), both containing regions with high sequence similarity to a family of proteins known to bind and hydrolyze ATP. This predicted domain topology foreshadowed functional studies of CFTR demonstrating that activation of CFTR C1-channels requires phosphorylation at one or more sites as well as the binding and hydrolysis of ATP (Anderson et al., 1991a; Berger et al., 1991; Cheng et al., 1991; Tabcharani et al., 1991; Bear et al., 1992; Carson and Welsh, 1993; Baukrowitz et al., 1994; Hwang et al., 1994) .
The two NBFs of CKI'R exhibit sequence similarity that is sufficient to allow the identification of analogous residues in the two domains (Riordan et al., 1989; Gregory et al., 1991) . In a previous study , we compared the effects of analogous mutations in NBF1 and NBF2 on the steady state activation kinetics of CFTR, assayed by determining the dose-response for the activation of cAMP-dependent C1-currents by the phosphodiesterase inhibitor, IBMX, in the presence of forskolin, an activator of adenylate cyclase. The results suggested that both NBFs function in the activation of CFTR, but in different ways. Mutations of an invariant glycine in either NBF1 (G551) or NBF2 (G1349) produced similar reductions in the sensitivity to activating conditions. In contrast, mutations in the putative ATP-binding pockets of the two NBFs produced opposite results, a reduction in sensitivity for mutations in NBF1 (K464Q, D572N) and an increase in sensitivity for the analogous mutations in NBF2 (K12500~ D1370N).
In the studies described here, we characterized the roles of the two NBFs in the opening and closing of CFTR C1 channels by measuring the rates of activation and deactivation of C1-conductance associated with wild-type CFFR and mutants bearing single amino acid substitutions in NBF1 or NBF2. Using a two-state model for activation, we examined the roles of each NBF in regulating access to the activated state (on rate) and in determining the stability of the activated state (off rate). The results are compatible with a scheme in which the two NBFs interact to effect activation of CFTR in a manner such that ATP binding and hydrolysis at NBF1 is critical for entering the active state, but ATP binding at NBF2 also contributes to this process. Both NBFs appear to influence the stability of the active state, but in opposite ways, NBF1 stabilizing and NBF2 destabilizing the conducting conformation. Some of this work has been presented in abstract form (Wilkinson et al., , 1994 .
MATERIALS AND METHODS

Site-directed Mutagenesis, Plasmid Construction, and RNA Synthesis
CFTR mutants were generated as described previously by cloning Sph I-Sac I fragments of the CFTR cDNA into the pSelect vector (Promega Corp., Madison, WI) and performing site-directed mutagenesis, using oligonucleotides that corresponded to the desired mutations. A 1.7-kb fragment of the cDNA that includes the Walker A region of NBF1 was used to make mutations at lysine 464, while a 3.0-kb fragment that includes glycine 551 and the Walker B region of NBF1 as well as glycine 1349 and the Walker A and B regions of NBF2 was used to make mutations at those sites. Mutations were verified by sequencing, and the mutated fragments were transferred into a full-length CFTR cDNA construct (Drumm et al., 1990) in pBluescript (Stratagene Inc., LaJolla, CA), RNA was synthesized by in vitro transcription, as described previously (Drumm et al., 1991) , then suspended in diethylpyrocarbonate-treated water for injection.
Oocytes and RNA Injection
Female toads (Xenopus laevis, Xenopus-I, Inc., Ann Arbor, MI) were anesthetized by immersion in ice water containing 3-aminobenzoic acid ethyl ester (Tricaine, 3 mg/ml, Sigma Chemical Co., St. Louis, MO), and oocytes were removed through a small abdominal incision. The follicular membranes were removed by blunt dissection after incubation for 2-6 h in a nominally Ca 2+-free denuding solution containing 82.5 mM NaC1, 2 mM KC1, 1 mM MgCI~, 5 mM HEPES (pH 7.5), and 2.5 mg/ml collagenase (Gibco Laboratories, Grand Island, NY). Defolliculated oocytes were kept overnight in a modified Barth's solution (MBSH) conmining 88 mM NaC1, 1 mM KC1, 2.4 mM NaHCO~, 0.82 mM MgSO4, 0.33 mM Ca(NO3)2, 0.41 mM CaC12, 10 mM HEPES, and gentamicin sulfate (150 mg/liter), then injected with 0.1-15 ng of RNA (50 nl volume) using a microinjector (Drummond Scientific Co., Broomhall, PA). Injected oocytes were incubated at 19~ in 96-well microtiter plates containing MBSH, with one oocyte per well. Injection pipettes were pulled from glass tubes (Drummond Scientific Co.), and the tips were beveled to minimize damage to the oocytes during injection. The internal surface of each pipette was neutralized by dipping the unbeveled end in a siliconizing agent (Sigmacoate, Sigma Chemical Co.) and baking the pipettes, tips up, at 200~ for at least 1 h.
Electrophysiology and Experimental Protocol
Oocytes injected 3-6 d previously were perfused individually with an amphibian Ringer's solution containing 100.5 mM Na +, 2 mM K +, 1.8 mM Ca ~+, 1 mM Mg 2 § 105.6 mM (11 , and 5 mM HEPES (pH 7.5). Each oocyte was impaled with two microelectrodes, the membrane potential (V,10 was clamped using a two-electrode voltage clamp Dagan Instruments, Minneapolis, MN) , and membrane currents (/m) were measured. The value of/,,, at a holding potential of -60 mV was monitored continuously on a chart recorder. The membrane conductance (g) at -60 mV was determined by stepping V,,, from -60 mV to -120 mV, then clamping V,n to voltages between -120 and +40 mV using a computer-driven ramp command (Clampex, Axon Instrnments Inc., Foster City, CA) that changed the voltage at a rate of 100 mV/s. The l-Vrelationship was constructed from the digitized values of /,,, and V,,,, and the conductance at -60 mV was calculated from the slope of the 1-Vrelationship between -70 and -50 inV.
The time course for activation of CFTR (11-conductance was determined by changing the oocyte perfnsate to a Ringer's solution that contained 10 ~M forskolin and 5 mM 3-isobutyl-1-methylxanthine (IBMX). Forskolin (Research Biochemicals International, Natick, MA or Sigma Chemical Co.) was added from a 20-raM stock in ethanol and IBMX (RB1 or Sigma Chemical Co.) was added from a 500-raM stock in dimethylsulfoxide. In tininjected or water-injected oocytes, the membrane conductance at -60 mV was not affected by the cocktail of forskolin and IBMX, but in oocytes expressing CFTR, a time-dependent increase in membrane conductance was elicited (see Drumm et al., 1991) . The maximum possible concentration of IBMX (5 raM) was chosen to maximize the activation rate of cAMP-dependent protein kinase and to optimize the activation level of insensitive CFTR mutants so that all variants could be compared under identical conditions. The time course for activation was determined by measuring the conductance periodically until no further increase was discernible, indicating the establishment of an activated steady state. The CFTR C1-conductance activated at any time after addition of forskolin and IBMX, gel(t), was calculated by subtracting the background conductance measured before the addition of the drugs. To account for variability in the activation rates caused by differences in the level of CYI'R expression among oocytes, the values of gcl(t) were normalized to the maximum conductance, gel(max), measured in the activated steady state.
The activation of CFTR C1-conductance was described over most of its time course by a single exponential, as illustrated for wild type CFTR in Fig. 1 . The activation rate was quantified by fitring a single exponential function to the data points between 15 and 85% of maximal activation. This range effectively excluded very early times, during which activation of the cytosolic enzymes was likely to be rate limiting, and very late times, when the rate of rise was slow and more difficult to quantify.
To examine the kinetics of CFTR deactivation, we monitored the time course for deactivation of CFI'R C1 conductance after washout of forskolin and IBMX from the perfusate. Membrane conductance was measured in the activated steady state and periodically after changing the perfusate back to normal Ringer's solution, until no further change was discernible. The activated CFTR conductance remaining at any time after the solution change (time 0) was estimated by subtracting the value of the minimum membrane conductance measured in the deactivated FIGURE 1. Representative time course for activation of wild-type CFTR expressed in Xenopus oocytes. CFTR C1-conductance (gc0 was determined periodically after addition (at time 0) of 10 IxM forskolin and 5 mM IBMX to the oocyte perfusate. The measured values, gel(t), are plotted as a percentage of the maximum value, gel(max), measured in the activated steady state. In this experiment, the value of gel(max ) was 23.4 t~S and the background membrane conductance before stimulation was 1.9 I~S. The inset shows the normalized conductance values between 15 and 85% of gel(max) plotted on a natural logarithmic scale, for estimation of (ko, + k~,ft) according to Eq. 1. From the linear regression (solid line), the value of (k~,,, + koft-) was 0.866 min -1 with a regression coefficient (r 2) of 0.992. steady state. These values were then normalized to the maximum value of gel observed during the deactivation time course.
The deactivation of CFTR C1-conductance was more complex than activation, as illustrated in Fig. 2 . Representative time courses are shown for wild type CFTR and two variants, K464Q and K1250Q. The former exhibits reduced steady state sensitivity to activation, whereas the latter exhibits increased sensitivity . The characteristic time course for deactivation of wild-type CFTR was a transient increase in gcl followed by a decline toward baseline. We interpreted the increase in gel as the relief of IBMX block of CFTR, which has been documented in studies of single CFTR channels (Richards, Marth, and Dawson, unpublished observations; Schultz et al., 1994) . The transient increase in gel was most evident for wild-type CFTR and mutants such as K1250Q, which remained fully activated for several minutes after washout of IBMX. In contrast, the decline in gel for mutants such as K464Q was rapid, showing only a slight increase after IBMX withdrawal. In view of this transient behavior, we chose to characterize the rate of deactivation in terms of two parameters: (a) the latency between drug removal (time 0) and deactivation to 85% of maximum gcl, and (b) the rate of decline between 85 and 15% of maximum gcl-For wild-type CFTR, the second component appeared to consist of two phases, an initial slow decline followed by a faster decline, but for comparison this was approximated by a single exponential decay because for all of the CFTR mutants examined here, the second component was well described by a single exponential (Fig. 2) .
Interpretation of Activation and Deactivation Rates
In view of the fact that the rates of activation for wild-type and the mutant CFTRs examined here were dominated by single exponential time courses, we interpreted the rate of approach to the steady state gel in terms of a model that recognizes only two states, inactive (I) and active (A). kon I\ \A.
k,, f~
In this scheme, k,,. represents the lumped rate coefficient for reactions and conformational changes that contribute to establishing the active state, and ko~ represents the lumped rate coefficient for the reactions and conformational changes involved in the return to the inactive state. The coefficient ko~-is a measure of the stability of the activated state under activating conditions and should be distinguished from the off rate that was measured following removal of the activating stimulus. We designate this latter parameter as *ko,-, which is a measure of the stability of the active state in the absence of activating conditions (see below). For the two-state model, the rate of approach of gel to steady state activation is described by gcl(t) = gel(max) 9 (1-exp[-(kon+ ko,) t]), (1) and the value of (k,,, + kofr) is given by the slope ofa semilogarithmic plot of 1 -gcl(t)/gc~(max) vs t. The values of ko, and kott that characterize the approach to steady state activation can be calculated if the apparent Kl/2 for steady state activation (KA) is known. The dose-dependent, steady state activation of CFTR by IBMX can be described by a single rectangular hyperbola. In previous studies (Drumm et al., 1991; Snfit et al., 1993) , we estimated the apparent KA for dose-dependent activation from loga- rithmic dose-response plots, but for comparison with rates of activation we sought a more unbiased estimate of Ka that took into account three factors: (1) the activation produced by forskolin alone, (2) the block of CFTR by high concentrations of IBMX, and (3) the fact that for insensitive mutants such as G551D, D572N, and G1349D the dose-response showed no tendency toward saturation at the highest concentrations of IBMX. Accordingly, we assumed that if the steady state dose-response data were corrected for the small response in the presence of forskolin alone, then the activated gcJ would be the sun] of two components, one caused by activation of CFTR by IBMX and a second caused by blockade of activated CFTR by IBMX:
where ghl/~ 'x is the ratio of the steady state conductance activated by a particular concentration of [BMX to the maximum IBMX-activated conductance actually observed in the same experiment, ~'~ is the hypothetical maximum gel that would be ohstowed at maximum activation of CFTR in the absence of block, and K~ and K I are the values of Kwz tbr activation and block, respectively. The block of CFTR by IBMX was assumed to represent a unimolecular binding event. Single-channel records suggest that the kinetics of block are fast, reducing the apparent amplitude of single-channel currents (Richards et al., unpublished observations; Schultz et al., 1994) . We assumed that the maximum blockable conductance was equal to the maxinmm activatable conductance and that the value of K I was the same for all of the CFTR variants examined. The Kj fbr IBMX block was estimated from the response of the hypersensitive mutant, K1250A. Because K1250A is maximally activated at an IBMX concentration of,'-,1 raM, the block by higher concentrations of IBMX is readily apparent. The continuous curve in Fig. 3 A shows the fit of Eq. 2 to the dose-response data. Nonlinear regression yielded values of ~'~1/~x = 1. l 7 -4-0.03 and Ki = 9.5 _+ 1.4 mM. Values of Kx for wild type and all of the mutants were obtained by assuming that the value of KI tor IBMX block was 9.5 raM. Eq. 2 was fit to the data from individual experiments to provide the most unbiased estimate of the variance in K a. The value of N'!I/N'~I ~ estimated for the mutant K1250A indicated that the maximum gcJ actually observed, g~'!i ~'X, was nearly equal to the maximum possible activation, N'~l, presumably because this conductance is achieved at an IBMX concentration of 1 raM, where block is minimal. The calculated curves for activation and block of K1250A are shown in Fig. 3 A, where the values of gel are normalized to the theoretical maximum, N'!]. For this mutant, the two components of the dose-response to IBMX are well separated such that at concentrations of IBMX below ~1 mM the activation of CFTR predominates, whereas at higher concentrations the conductance is progressively attenuated by 1BMX block. The magnitude of the transient increase in gel tor K1250A after removal of 5 mM IBMX in the rate experiments (cf. Fig. 5 B) was consistent with this interpretation. The peak value of get measured during the deactiw~tion time course was ~35% greater than the vahm measured in the presence of 5 mM IBMX, as predicted for a Ki of 9.5 mM. For wild-wpe CFTR and the mutant K464Q, the observed values of ~'!i '• were ~60% and 27% of the theoretical maximum g'cl, respectively. For these CFTR variants, the activated ,g{:l does not approach the theoretical maximum conductance for two reasons: (a) the values of K a are higher, so the activated get is proportionately lower at any concentration of IBMX, and (b) the The measured values of gel are shown normalized to the theoretical maximum, g~q. The continuous curve shows the fit of Eq. 2, and the dashed and dotted curves show, respectively, the components of activation (KA = 0.07 mM) and block (Kl = 9.5 mM). (B) IBMX dose-response relations for steady state activation of K1250A (~), wild-type CFTR (Q, n = 26), and K464Q (A, n = 5). The data points were corrected for block using/~ = 9.5 mM. The continuous curves show the activation predicted by the values Of KA, which were 0.07, 0.65, and 3.3 mM, respectively. block by IBMX becomes appreciable above 1 raM. In Fig. 3 B, the activation components for wild-type CFTR and the mutants K1250A and K464Q were simulated by adding back the blocked component and plotting the adjusted data points along with the curves calculated using the estimated KA values.
In view of the hyperbolic dose-response for steady state activation ( Fig. 3/3 ) and the first-order kinetics of activation ( Fig. 1) , we assumed that the ko, for CFTR activation could be expressed as the product of the IBMX concentration and a lumped, pseudo first-order rate coefficient, k'o~, where
and the value of K A for steady state activation is given by
Using these relations, values for k',,. and ko~ in the activated steady state (5 mM IBMX) can be calculated from the measured values of (ko. + k,,fO:
and
As indicated previously, the rate of deactivation of g(a after abrupt removal of the activating conditions was complex and was described by two empirical parameters, a latency to 85% of (g~;i) .... and an exponential decline given by
where ga(max) is the peak value of gcl during washout of IBMX and forskolin, and *k,,~ is the exponential off rate following the initial transient in gel (t) . The values of *k,,~ tended to be greater than the corresponding estimates of kofr, the calculated off rate under activating conditions, as expected if some feature of these conditions reduced the deactivation rate. For example, IBMX may inhibit phosphatase activity, as suggested by the work of Becq et al. (1993) , and/or IBMX itself may stabilize the active state of CFTR (Schuhz et al., 1994) . Generally, however, muta-107 WILKINSON ET AL.
tions induced qualitatively similar changes in ko, and *koff, suggesting that these two independent measures provide similar impressions of changes in the stability of the active state of CFTR.
Statistical Comparisons
The values of K, and the rate analysis parameters for each mutam were compared with those for wild-type CFTR and with those for other mutants using a one-way analysis of variance and Fisher's post hoc test of least significant differences. Analysis of variance is most appropriate if the variance is constant across individual groups, but in the present case the variance tended to be proportional to the magnitude of the parameter in question. Therefore, the variance for each parameter was stabilized before statistical analysis by taking the logarithm of all values (Snedecor and Cochran, 1967) .
RESULTS
Mutations in the Nucleotide Binding Folds Dramatically Altered the Rates of Activation and Deactivation of CFTR
The rate of activation of CFTR in oocytes is determined by the properties of a multistep reaction, which involves not only the dynamics of CFTR itself but also the properties of cellular enzyme systems governing the activities of protein kinases and phosphatases. To minimize the time required for elevation of cytosolic cAMP and protein kinase A activity, we used forskolin and the maximum possible concentration of the phosphodiesterase inhibitor, IBMX. Mutations in CFTR can be reasonably expected to affect the response of CFTR to activating conditions, but not the dynamics of cellular enzyme systems. In the course of this study, we found that NBF mutations associated with altered values for the (KA)mMX caused dramatic changes in the macroscopic kinetic parameters measured here. The values listed in Table I show that NBF mutations generally reduced the value of (ko,, + ko~), in some cases by more Values were determined as described in Methods. The symbols (*) and (~) indicate significant differences from wild-type CFFR and the analogous mutant, respectively (P < 0.05).
than 10-fold. Likewise, values for the latency and *ko~ were markedly mutant dependent, the former decreasing by as much as 10-fold or increasing by as much as 3.7-fold compared with the wild type. Such changes are consistent with the notion that the rates of activation and deactivation measured here reflect the kinetics of the conversion of CFTR from an inactive to an active state. Using the values Of KA and (kon + koff) listed in Table I, it is possible to calculate values for the apparent kon (or k'on) and koff that characterize the approach to steady state activation. For wild-type CFTR, for example, ko,i = 0.588 +-0.045 min -1 (k'on = 0.118 + 0.009 min -1 mM -l) and koff = 0.076 + 0.006 min -1, suggesting that, at 5 mM IBMX, the rate of relaxation was dominated by the on rate, as expected. A strict interpretation of these rates in terms of a two-state, closedopen channel-gating process would require closed times of the order of 1.7 min and open times of :'-'13 min. The gating of CFTR C1-channels in cell-attached membrane patches has not been studied extensively, but there is no suggestion in the available data for open and closed times of this magnitude. This suggests that there is a slow component to the dynamics of CFTR activation that is reflected in the rates determined here (see Discussion). In addition, however, it is possible that the activation rate may be artifactually reduced by the finite rate of rise of intracellular PKA activity. Despite this possible attenuation, the relative changes in kinetic parameters associated with NBF mutations provide an approach to characterizing the mutationinduced changes in accessibility or stability of the active state. Our mutational analysis focused on three residues that can be identified unambiguously in the two NBFs because of their locations within primary sequence motifs either in ATPases generally or specifically within the family of traffic ATPases. In each NBF, we substituted the invariant glycine (G551 in NBF1 or G1349 in NBF2), which lies in a region that is characteristic of traffic ATPases (Hyde et al., 1990; Mimura et al., 1991) , is invariant among CF-FRs of different species (Diamond et al., 1991; Tucker et al., 1992) , and is associated with mutations that cause cystic fibrosis (Cutting et al., 1990; Kerem et al., 1990; Strong et al., 1991) . The other two sites lie within primary sequence motifs that form part of the nucleotide binding pocket in ATPases and GTPases for which crystal structures are available (see Discussion). The Walker consensus A motif (Walker et al., 1982) forms a glycine-rich, phosphatebinding loop in the hydrolytic core of ATPases and GTPases, and the invariant lysine near the carboxyl end of this motif participates in the binding and hydrolysis of ATP through associations with the [3-and ~-phosphates of ATP. The Walker consensus B motif (Walker et al., 1982) is also located within the phosphate-binding portion of the binding pocket, and the highly conserved aspartic acid at the carboxyl end of this motif may also participate in ATP hydrolysis. In Results and Discussion, we refer to the invariant glycine in relation to G551 in NBF1 or G1349 in NBF2 and to the ATP-binding pocket in reference to the Walker consensus A lysines (K464 in NBF1 and K1250 in NBF2) or the consensus B aspartic acids (D572 in NBF1 and D1370 in NBF2). Although there is presently no definitive structural information for either NBF of CFTR, this nomenclature is useful for presenting the results of mutations at these sites.
Steady State Activation of NBF Mutant C~7"Rs
The values of KA obtained by curve fitting (Table I ) are in accord with the qualitative analysis presented previously (Smitet al., 1993) . The values of KA determined for the mutant CFTRs all differed significantly from that of wild-type CFTR (P < 0.05). Substitutions for the invariant glycine in either NBF produced similar increases in KA, with the exception of the mutation that was conservative with respect to polarity and size, alanine for glycine, which in NBF1 (G551A) produced a nearly fivefold increase in KA but in NBF2 (G1349A) produced less than a twofold increase. In contrast, substitutions for conserved residues in the putative ATP binding pocket produced opposing effects on KA. Substitutions in NBF1 increased KA from fourfold to 14-fold over that seen with wild-type CFrR, whereas the comparable substitutions in NBF2 decreased KA by fourfold to ninefold. These differential shifts in KA were an initial indication that NBF1 and NBF2 play different roles in the activation of CFTR.
Rate Analysis of Invariant Glycine Mutants
Substitutions for the invariant glycine in either NBF1 (G551) or NBF2 (G1349) significantly slowed the rate of approach to steady state activation (kon + kofr) coinpared with wild-type CFTR, and the reductions produced by the substitutions in NBF1 were more profound than those produced by the analogous substitutions in NBF2 (P < 0.05). The reductions in the relaxation rates can be seen clearly in the representative traces shown in Fig. 4 A and in the values of (kon + kofr) listed in Table I . In NBF1, substitution to alanine (G551A), the most conservative change possible, reduced the relaxation rate by more than sixfold, and the less conservative substitutions to serine (G551S) and aspartic acid (G551D) progressively reduced the relaxation rate. At the analogous site in NBF2, the most conservative substitution (G1349A) also reduced the relaxation rate, but by only about threefold. Substitutions to serine (G1349S) and aspartic acid (G1349D) produced progressive reductions such that the relaxation rate for the least conservative mutation, G1349D, was about twice that for the comparable mutation in NBF1.
The values of (ko,, + korf) observed with the analogous mutations in NBF1 and NBF2 suggested that the observed increases in KA (koJk'o,) arose primarily from a decrease in the on rate. This impression is confirmed by an examination of the values calculated for the apparent k'on and kofr, which are shown in Table I and compared in Fig. 5 . Substitutions for G551 in NBF1 reduced the on rate more dramatically than the analogous substitutions for G1349 in NBF2. In NBF1, these substitutions reduced the on rate by 9-to 30-fold and slightly reduced the apparent off rate under activating conditions (kotf), suggesting that the increase in K A was due to a reduction in the accessibility of the active state FIGURE 5. Summary of mutation-induced effects on the activation parameters. Values for the pseudo-first-order on-rate coefficient (k',,,) and for the off-rate coefficient (k,,a) were calculated using the measured values of (k,,n + k,,l,) and the corresponding estimates of Kx (Eqs. 5 and 6). Points are means +_ SEM for the ratios of the mutant values to the mean wild-type value (number of experiments listed in Table I or Table II that was ameliorated slightly by a smaller but significant stabilization of this state. The analogous substitutions in NBF2 also reduced the on rate, but only by 3-to 15-fold. Here also, the increase in KA was primarily due to reduced accessibility of the active state. In either NBF, the progressively less conservative substitutions to alanine, serine, and aspartic acid induced significantly greater attenuations of the on rate.
Comparisons of the deactivation rates for glycine-substituted mutants (Table I ) revealed differential effects on the stability of the active state that were not apparent in the calculated values of kof~.. Representative time courses for deactivation of NBF1 and NBF2 mutants are shown in Fig. 6 A, and values for the latency and *k,,~ are compared in Fig. 7 A. Substitutions tor the invariant glycine in NBF2 (G1349) severely compromised the stability of the active state. Here, even the most conservative replacement (G1349A) dramatically shortened the latency and significantly increased the rate of exponential decline. This destabilization of the activated state is clearly evident in the representative time courses for deactivation of the mutants G1349S and G1349D (Fig. 5 A) .
The effects of substitutions for the invariant glycine in NBF1 (G551) on deactivation were generally less substantial.
The most conservative substitution (G551A) did not appreciably alter the latency. The less conservative substitutions (G551S, G551D) progressively decreased the latency, but the reductions were always less than those induced by the corresponding mutations (G1349S, G1349D) in NBF2. The progressive destabilization of the active state suggested by the decreased latency seen with the G551S and G551D substitutions was not evident, however, in the subsequent phase of exponential decline. The values of *k,~ were similar to that for wild-type CFTR.
Rate Analysis of A TP-Binding Pocket Mutants
The rates of approach to steady state activation for mutants of the putative ATP-binding pockets confirmed the impression that both NBF1 and NBF2 are involved in gaining access to the active state and suggested that NBF2 is particularly important for determining the stability of the active state. The representative time courses in Fig. 4 B show that substitutions for the Walker consensus A lysine in either NBF produced comparable reductions in the relaxation rate (ko, + ko~r). As shown in Table II , substitutions for the lysine in NBF1 (K464) reduced the relaxation rate (ko,, + k~,f~) and increased K A (koff/k',m), so the decrease in the relaxation rate was due to a decrease in the on rate. The effects of the alanine, glutamine, and arginine substitutions were similar, resulting in 66-83% decreases in k'o,. Although significant, these reductions were somewhat less than those seen with the substitutions for the invariant glycine in NBF1 (G551). The calculated values of k,,~. for K464Q and K464A indicated that the substitutions to alanine or glutamine also increased the off rate under activating conditions, which contributed to the increase in Ka and compensated somewhat for the reduction in relaxation rate caused by the reduced on rate. In contrast, the more conservative arginine substitution actually appeared to cause a modest stabilization of the active state.
The comparable substitutions for the lysine in NBF2 (K1250) produced relaxation rates that were generally similar to those seen with their NBF1 counterparts, because of similar reductions in the on rate (k',m). In addition, however, substitutions at this site produced a profound reduction in the apparent korr. Although this additional reduction in the off rate was not immediately apparent in the relaxation rates (ko, + k,,~O because of the proportionately small contribution of the off rate, this apparent stabilization of the active state accounts for the values of K A that were from 3.8-to 9-fold smaller than that for wild-type CFTR, rendering these mutants hypersensitive to activating conditions. The substitution of asparagine for the Walker con- sensus B aspartic acid in NBF1 (D572N) produced a profound reduction in the rate of approach to steady state activation ( Fig. 4 C) ; the value of (kon + kof0 was comparable with that seen with the G551A mutation (cf . Tables I and II) . Although the calculated parameters are less reliable because of the relatively high value of the apparent KA, the value of the apparent k'nn is consistent with a marked reduction in the accessibility of the active state whereas the apparent off rate was not different from that of wild-type CFTR. In contrast, the analogous substitution in NBF2 (D1370N) produced only a modest decrease in (ko, + kor0, evident in Fig. 4 C. The values of the derived parameters (k'o,, ko~) for this slightly hypersensitive mutant, however, suggest that the decrease in K A was a reflection of a fourfold decrease in ko~, whereas the apparent kon was not significantly different from that of wild-type CFTR. Values of the calculated ko~ for CFTRs bearing mutations in the putative nucleotide binding pocket of NBF1 or NBF2 suggested that these two domains play different roles as regards the stability of the active state. This dichotomy was also evident in the deactivation parameters that were measured directly (Fig. 5, B and C) . In NBF1, substitutions for the consensus A lysine (K464) or the consensus B aspartic acid (D572) decreased the latency to 15-32% of the value for wild-type CFTR and significantly increased the measured off rate (*kon-), indicating destabilization of the active state (Table II, Fig. 7 ). In contrast, substitutions at the analogous sites in NBF2 (K1250 or D1370) actually increased the latency by two-to threefold, and, with the exception of the most conservative substitution, K1250R, the values of *koff were decreased compared with that of wild-type CFTR, indicating stabilization of the active state. These results suggest that the consensus A lysine and consensus B aspartic acid in the ATP binding pocket of NBF1 contribute to stabilization of the active state, whereas their analogues in NBF2 are involved in terminating the active state. Particularly noteworthy in this regard is the D1370N mutation, which produced no significant effect on the apparent on rate but markedly delayed deactivation.
In NBF2, the effects of substitutions at sites in the putative ATP-binding pocket (K1250 and D1370) on deactivation were clearly opposite to the effects of substitutions for the invariant glycine (G1349). The former markedly delayed deactivation, as reflected in the increased latency and decreased *ko~, whereas the latter Table I or Table II) . A and B are the same as Fig. 6 . markedly hastened deactivation, as signaled by the reduced latency and increased *kotf (cf. Figs. 5 and 7) . In NBF1, mutations at sites in the ATP binding pocket (K464 and D572) also produced effects that were different from those of substitutions for the invariant glycine (G551). Here, however, mutations in the binding pocket clearly hastened deactivation, evidenced by decreases in the latency and increases in *kom while the mutations of glycine 551 moderately decreased *kom The latency was also decreased progressively by the less conservative mutations, G551S and G551D. In general, the effects of mutations on the latency were mirrored by those on the value of *kom although the latter were often less marked. For example, the NBF2 glycine mutants exhibited increased values of *kot ~ in conjunction with the decreased latency, as did the mutants of the NBF1 binding pocket. Similarly, the value of *ko~was reduced for most of the NBF2 binding pocket mutants, which also exhibited increased latencies. There were exceptions to this pattern, however. For mutants of the NBF1 glycine (G551S and G551D) , the values of *kon. did not increase in conjunction with the progressively decreased latency. Similarly, although the K1250R and D1370N mutants exhibited an increased latency, the values of *ko~ were not significantly different from that of wild type CFTR.
DISCUSSION
Analyzing the functional properties of CF-fRs bearing mutations in the nucleotide binding domains is one approach to testing hypotheses for the roles of these domains in activation and deactivation. Our analysis focused on analogous residues in two regions of each NBF: an invariant glycine (G551 or G1349) that is a signal feature of the traffic ATPase superfamily and two other residues, the invariant Walker A lysine (K464 or K1250) and the highly conserved Walker B aspartic acid (D572 or D1370), which are likely to lie within the hydrolytic core of the ATP-binding pocket. The results indicate that NBF1 and NBF2 play distincdy different, The symbols (*) and ('`) indicate significant differences from wild-type CFTR and the analogous mutant, respectively (P < 0.05).
although overlapping, roles in the cycle of CFTR activation and deactivation. Both NBF1 and NBF2 are important for accessing the activated state, but the results of rate analysis suggest a dominant role for NBF1 in this process. Similarly, both NBFs influence the stability of the active state, but in different ways. Mutations in the ATP-binding pocket of NBF1 destabilized the active state, whereas the analogous mutations in NBF2 stabilized the active state, suggesting that NBF2 plays a major role in regulating the termination of the active state. The effects of mutations in the ATP binding pockets speak in favor of a role for ATP hydrolysis in the activities of both NBFs but suggest that at NBF1, ATP hydrolysis is associated with activating CFTR, whereas at NBF2, ATP hydrolysis provides a mechanism for timing the duration of the active state. Finally, the results suggest that within each NBF, the functional role of the invariant glycine (G551 or G1349) is distinctly different from those of either the lysine (K464 or K1250) or the aspartic acid (D572 or D1370) in the ATP-binding pocket.
NBFI : Activation and Stabilization
The results of rate analysis suggest that ATP-dependent processes involving NBF1 are critical for activating CFFR C1-channels and for maintaining the channels in the active state. This conclusion is based on the observation that substitutions in NBF1 profoundly affected both the accessibility and the stability of the active state. Substitutions for the invariant glycine (G551), the consensus A lysine (K464), or the consensus B aspartic acid (D572) reduced the value of k'on ( Fig. 6 ). In addition, the effects on the latency parameter suggest that the substitutions in either the consensus A or B regions of NBF1 markedly destabilized the active state. These findings are consistent with a scheme in which ATP hydrolysis at NBF1 is the crucial event in ATP-dependent activation and the active state is stabilized by some product of ATP hydrolysis. A role for ATP hydrolysis at NBF1 in the activation of CFI'R is supported by functional evidence from other laboratories. Using detached membrane patches from transfected NIH-3T3 fibroblasts, Anderson et al. (1991a) showed that after exposure to a phosphorylating environment, CFTR CI-channels were activated only in the presence of hydrolyzable ATP analogues, an observation subsequently confirmed in detached patches from transfected HeLa cells (Carson and Welsh, 1993) , in guinea pig cardiac myocytes , in lipid bilayers after fusion of membrane vesicles from transfected HEK 293 cells (Gunderson and Kopito, 1994) , and in detached patches from transfected mouse L cells (Schultz et al., 1995) . Phosphate analogues such as orthovanadate and beryllium trifluoride prolonged the opening of CFTR C1-channels, but only after they had been opened by ATP (Baukrowitz et al., 1994; Gunderson and Kopito, 1994) . These effects were not definitively localized to NBF1 but are consistent with the notions that ATP hydrolysis is required for activation and that phosphate analogues stabilize the active state of CFTR by slowing the dissociation rate of the hydrolysis product, ADP. Thus, mutations in NBF1 that compromise either ATP binding or hydrolysis, or the coupling of these events to the channel-gating mechanism, would be predicted to slow activation, as seen with all of the NBF1 mutations examined here. Furthermore, mutations that reduce the affinity for the hydrolysis product ADP would be predicted to destabilize the active state, as seen here with mutations of the consensus A lysine or the consensus B aspartic acid in NBF1.
NBF2: Activation and Termination
A striking result of the mutational analysis was the finding that substitutions for the consensus A lysine (K1250) or the consensus B aspartic acid (D1370) in the putative ATP-binding pocket of NBF2 dramatically stabilized the active state of CFFR. These findings suggest that an interaction of ATP at NBF2 regulates the duration of the active state. This notion is consistent with the observations of Hwang et al. (1994) , who showed that the nonhydrolyzable ATP analogue, AMP-PNP, could stabilize the open state of cardiac CFTR C1-channels previously opened by exposure to ATP. The interdependence of the actions of ATP and AMP-PNP was interpreted as an indication that after the binding or hydrolysis of ATP at one NBF (NBDA), AMP-PNP could bind at a second site (NBDB). The stabilizing effect of AMP-PNP on CFTR gating, also demonstrated by Gunderson and Kopito (1994) , was interpreted as an indication that the rate of ATP hydrolysis at NBDB times the duration of the active state. As discussed below, structural and functional studies of other ATPase proteins support the idea that substitutions for the consensus A lysine or the consensus B aspartate in the ATPbinding pocket would be likely to alter the rate of ATP hydrolysis. The rate analysis of CFTR mutants presented here is consistent with the notion that the NBDB of Hwang et al. (1994) is, in fact, NBF2 and that ATPdependent processes at this site regulate the termination of the active state. In a recent report, Gunderson and Kopito (1995) presented evidence for a cyclic gating scheme for CFI'R comprising at least one closed and two distinct open states, Oa and 02, that were distinguished by a small difference in single-channel conductance. They proposed that ATP hydrolysis at NBF2 can regulate the stability of the open state of CFTR by controlling the transition from the more stable Oa state to the less stable 02 state.
The results from different laboratories regarding the effects of the nonhydrolyzable analogue AMP-PNP on ATP-dependent gating of CFTR are not entirely consistent. Carson et al. (1995) studied CFTR gating in detached patches from stably transfected C127 mouse mammary cells. Exposure of wild-type CFTR to AMP-PNP prompted the appearance of a distinct population of longer openings, but these made a relatively small contribution to the open probability. Furthermore, in detached patches from mouse L cells, Schultz et al. (1995) found no effect of AMP-PNP on either open probability or the efficacy of ATP. The discrepancies between these results and those reported by and Gunderson and Kopito (1994) could be related to the phosphorylation state achieved in detached patches or to other, as yet unresolved, methodologic differences. Schultz et al. (1995) called attention to a possible role for temperature in determining the gating kinetics of CFTR. Reducing the temperature from 35 to 25~ increased the open probability in multichannel patches to near unity, and this effect was observed only in the presence of PKA, despite the fact that the enzyme was not required to maintain activity with a lower open probability. Those results suggested that temperature, in addition to the phosphorylation state, is important for determining the gating state of CFTR. The present experiments were conducted at temperatures ranging between 19 and 21~ and indicate clearly that in the intact oocyte maximally stimulated by forskolin and IBMX, mutations in NBF2 of CFTR can lead to a profound stabilization of the active state. Thus, in the oocyte, although CFTR gating may be slowed, it seems unlikely that this temperature, per se, increases Po to near unity. Structural alterations in NBF2 also significantly slowed the activation of CFTR. Thus, although the mutation analysis assigns to NBF2 a primary role in timing the active state, this domain is also clearly involved in accessing the active state. There are at least two ways in which NBF2 could function in the activation of CFTR. ATP-dependent events at NBF2 could contribute to the conformational changes that underlie channel opening in a manner that is independent of NBF1, or NBF2 could act by modulating or otherwise contributing to events at NBF1. The latter view was proposed by Baukrowitz et al. (1994) as a mechanism for the stabilizing effect of NBF2. Of particular interest in this regard was the effect of the NBF2 mutation, D1370N. This substitution increased the stability of the active state but failed to significantly alter the on rate. This dichotomy suggests that it is possible to interfere with the timing function of NBF2 without affecting its role in accessing the active state. If it is assumed that this substitution acts by reducing the rate of ATP hydrolysis but not ATP binding, then the results imply that the binding of ATP at NBF2 is sufficient for its participation in activation.
In this view, ATP hydrolysis at NBF1 drives the conformation change that activates the channel, and NBF2 participates in activation as a modulator of events at NBF1.
Roles of the Consensus A Lysine and Consensus B Aspartic Acid
Structural studies of ATPase proteins offer some insights into the possible functional roles of the A and B consensus regions in NBF1 and NBF2 of CFTR. These regions form portions of the ATP-binding pockets in ATPase proteins with otherwise diverse primary sequences and functions. The consensus A motif, which forms a phosphate-binding loop (P-loop) common to both ATPase and GTPase proteins (Saraste et al., 1990) , is identified by the amino acid sequence G-X-X-G-X-G-K-T/S, in which the bold glycines (G) and lysine (K) are invariant (Walker et al., 1982; Fry et al., 1986; Hyde et al., 1990; Mimura et al., 1991) . The crystal structures of several ATPases and GTPases, including the FrATPase (Abrahams et al., 1994) , adenylate kinase (Mfiller and Schulz, 1992) , the recA protein (Story and Steitz, 1992) , and the G-protein Gi0q (Coleman et al., 1994) , indicate that this glycine-rich loop spans the hydrolytic core of the binding pocket and that the invariant lysine interacts directly with the [3-and ~/-phosphate groups of bound ATP, implying roles for this lysine in both the binding and hydrolysis of ATP. Mutations of this lysine to arginine in the yeast RAD3 protein (Sung et al., 1988) , to alanine in the Escherichia coli UvrA protein (Thiagalingam and Grossman, 1991) , or to glutamine in the E. coli FrATPase (Senior et al., 1993) impaired ATPase activity. ATP binding was not affected by the alanine substitution hut was reduced by the arginine and glutamine substitutions, although these reductions were less marked than the reductions in ATPase activity.
The common location and apparently conserved role of the Walker consensus A lysine among ATPases and GTPases with diverse structures and functions suggest strongly that the analogous lysines in CFI'R are also located within the phosphate-binding, hydrolytic cores of the ATP-binding pockets in NBF1 and NBF2. Hence, substitutions for the lysine in NBF1 (K464) or NBF2 (K1250) of CFTR would be expected to impair both the binding and subsequent hydrolysis of ATP by the NBF bearing the mutation. The affinity for ADP is likely to be reduced also, as the analogous lysines in the recA and ras proteins interact with the [3-phosphate of ADP (Story and Steitz, 1992) or GDP (Tong et al., 1991) .
The Walker consensus B motif is identified generally by a stretch of four to six hydrophobic amino acids (h) followed by a highly conserved aspartic acid, (h)4_6-D (Walker et al., 1982; Fry et al., 1986; Hyde et al., 1990; Mimura et al., 1991) . Crystal structures of the recA protein (Story and Steitz, 1992) and bovine F1-ATPase (Abrahams et al., 1994) indicate that this aspartate also resides within the phosphate binding portion of the ATP-binding pocket. The position of this aspartate in the recA protein suggested a role in coordinating Mg 2+ (Story and Steitz, 1992; Story et al., 1993) . In contrast, no specific role was suggested by the position of this aspartate in F~-ATPase, and the role of coordinating Mg 2+ was assigned to a threonine adjacent to the Walker A lysine. Substitution of asparagine (N) for this aspartate in phosphoglycerate kinase reduced ATP binding and enzymatic activity (Minard et al., 1990) , and the equivalent substitution in E. coli F~-ATPase reduced the apparent affinities for Mg 2+ and Mg-ATP and diminished the maximum ATPase activity (Senior and Al-Shawi, 1992) . Although the structural and functional studies of these other proteins do not offer a completely coherent picture of the role of the Walker B aspartic acid, the results of the rate analysis for the CFTR mutant D1370N are consistent with a role for this aspartic acid in ATP hydrolysis.
Role of the Invariant Glycine
The functional importance of the invariant glycine in NBF1 (G551) or NBF2 (G1349) is evident from the existence of mutations (G551S, G551D, and G1349D) that are associated with cystic fibrosis in humans (Cutting et al., 1990; Kerem et al., 1990; Strong et al., 1991) . However, unlike the residues in the consensus A and B motifs, which are found across families of ATPases and GTPases, the invariant glycine is unique to the traffic ATPase superfamily, for which crystal structures are not yet available. It is therefore more difficult to predict how this residue might contribute to ATP-dependent processes. One view, supported by structural modeling studies of a bacterial permease, His P, suggests that this glycine is part of a linker region that couples the ATP binding pocket to other parts of the protein (Mimura et al., 1991; Shyamala et al., 1991 ) , so substitutions might impair the transduction of conformation changes induced by events in the binding pocket. Another view, suggested by structural modeling of the multidrug resistance protein (Hyde et al., 1990) , holds that this glycine is intimately associated with the binding pocket, so substitution might impact directly on the events of ATP binding and or hydrolysis. Support for the latter view is provided by the observation that the mutations G551D and G1349D impair ATP binding in isolated fusion proteins of NBF1 and NBF2, respectively (Logan et al., 1994) . On the other hand, the results of Anderson and Welsh (1992) suggested that the mutations G551S and G1349D reduced the open probability of CFTR C1-channels without changing the K~/2 for the effect of ATP concentration on open probability.
The rate analysis does not pinpoint the function of the invariant glycine, but some potentially important differences between effects of substitutions for the glycine and the consensus A and B residues are apparent. Most striking is the comparison of the effects of substitutions in NBF2 on the deactivation parameters. Replacement of G1349, even by alanine, markedly destabilized the active state, indicated by a dramatic decrease in the latency. In contrast, substitutions for the consensus A lysine (K1250) or the consensus B aspartic acid (D1370) stabilized the active state, as indicated by substantial increases in the latency. In terms of the linker model, this dichotomy could suggest that G1349 is involved in transmitting conformation changes necessary for timing the duration of the active state but does not affect the rate of ATP hydrolysis at NBF2. Alternatively, this glycine could be positioned such that substitution would impair the access of ATP to the binding pocket but not the hydrolysis rate. Yet another possibility is that substitution for this glycine actually increases the rate of ATP hydrolysis at NBF2.
A similar dichotomy was seen in the effects of glycine and binding pocket mutations in NBFI. The most conservative substitution for the glycine (G551A) dramatically attenuated the on rate but tended to stabilize the active state. Substitutions for the binding pocket residues (K464 and D572) also slowed activation, but markedly destabilized the active state. If the glycine functions as part of a linker, then mutations that compromise entry into the active state could also make it more difficult to revert to the inactive conformation. On the other hand, if mutations of the glycine act by obstructing the access of ATP to the binding pocket, this effect could also stabilize the ADP bound state somewhat. An increase in the rate of ATP hydrolysis as a result of glycine mutations in NBF1 seems unlikely, as this would be predicted to increase the activation rate.
Activation and Block of CUFR by IBMX
The goal of these studies was to examine the effects of mutations on the kinetics of transitions between the inactive and active states of the CFTR CI channel. Ideally, this would be done by subjecting the channel to a step increase in the local concentration of the catalytic subunit of protein kinase A. We attempted to approach this ideal in oocytes by using the highest possible concentration of IBMX (5 mM) to maximize the rate and extent of phosphodiesterase inhibition and, hence, the rate of activation of protein kinase A. In addition, concentrations of IBMX above 1 mM are required to achieve significant activation of CFTR mutants such as G551D, D572N, and G1349D (cf. Smit et al., 1993) . The use of 5 mM IBMX allowed us to compare insensitive, normal, and hypersensitive mutants on the same basis. The results indicate that mutations in the NBFs of CFI'R can have dramatic effects on the rates of activation and deactivation, as expected if the kinetics of the macroscopic cellular response are dominated by those reflecting transitions of the CFTR protein.
The analysis of the results was complicated somewhat by the fact that 5 mM IBMX produced significant block of the activated CFTR conductance. This effect was particularly noticable following the rapid washout of IBMX, when wild-type CFTR and the hypersensitive mutants exhibited a transient increase in gcl, consistent with rapid relief of IBMX block. The character of the deactivation following IBMX washout was highly mutant dependent, however, indicating that the dynamics reflected the effects of mutations on the deactivation properties of CFFR. We confirmed this by using forskolin alone to activate CFTR. This is not a satisfactory procedure in general because the response to forskolin alone is absent for insensitive mutants and transient for normal and hypersensitive variants, perhaps because of vigorous phosphodiesterase activity in the oocytes (Sadler and Maller, 1987) . It was possible, however, to compare the deactivation of wild-type CFTR and hypersensitive mutants. After washout of 10 tzM forskolin, there was no transient increase in gc~, but the rate of decline was Nfourfold slower for the hypersensitive K1250A mutant, which is consistent with the results seen with 5 mM IBMX. Similar results were obtained by activating with forskolin and 1 mM IBMX. These observations indicate that the procedure used here provides a useful comparison of the dynamics of activation and deactivation for CFTR mutants.
Implications of Macroscopic Rates for Single-Channel Gating
The rate of approach to steady state activation for CFTR-mediated C1-conductance was well described by a single exponential. If the gating of CFTR channels were a two-state process, then the values for kon and ko~ derived from rate analysis would reflect the mean dwell times in the closed and open states of the channel, respectively. Accordingly, a two-state model would predict mean closed times of 1.7 rain and open times of about 13 min for wild-type CFTR. Furthermore, the results presented here would predict that both of these dwell times can be dramatically altered by mutations in the nucleotide binding folds.
The gating of CFTR C1-channels has been studied in cell-attached and detached membrane patches from a variety of cell types expressing either native or recombinant CFTR. The minimal model that has emerged from such studies would comprise at least two closed states and one open state (Haws et al., 1992; Fischer and Machen, 1994; Venglarik et al., 1994; Winter et al., 1994; Schultz et al., 1995) . A simple C~ -~ C ~ ~O model can account for the observation that, in an activated steady state, CFTR gating occurs in bursts of rapid openings and closings separated by longer, interburst intervals. Furthermore, Carson et al. (1995) demonstrated in detached patches from transfected HeLa cells or 3T3 fibroblasts that the slow kinetics of steady state CFTR gating, i.e., burst length and interburst interval, are altered by mutations in the NBFs, in a manner that was, in part, consistent with the results presented here. For example, the mutation K1250A increased the burst duration of CFTR by four-to fivefold, and the analysis of CFTR deactivation in oocytes indicates that this substitution produced at least a threefold increase in the stability of the active state (Table II and Fig. 7) . Similarly, the mutation K464A increased the interburst interval by fivefold, whereas rate analysis revealed a nearly fourfold slowing of the activation rate (k'o,1). However, the open probability of K1250A was decreased by more than twofold, largely because of a 30-50-fold increase in the interburst interval, an effect that is not predicted by the present results.
The parallels between the effects of mutations on the activation rate and the single-channel gating are striking, despite the great disparity in the characteristic times of these two processes. The values of burst length and interburst interval observed by Carson et al. (1995) would predict an activation time constant of about 100 ms, whereas the time constant for activation of macroscopic C1-conductance in oocytes was ~800-fold slower. This disparity could be, at least in part, a result of the substantial methodologic differences in the two studies. We studied the activation of CFTR by endogenous kinase in oocytes at room temperature (18-20~ whereas Carson et al. exposed detached membrane patches from mammalian cells to the catalytic subunit of protein kinase A at 34-37~
In general, however, slower burst kinetics have been observed in on-cell recordings. For example, when CFTR was activated in Calu-3 human airway cells at room temperature using forskolin or isoproterenol (Haws et al., 1994) , the mean interburst interval was 38.4 s and the mean open time was 1.8 s, which would predict a time constant for activation of 1.7 s. In oocytes activated using forskolin and 1 mM IBMX, Richards and Dawson (unpublished observations) observed a mean interburst interval of ~16 s and burst lengths of ~1 s, consistent with a time constant for activation of ~1 s.
Despite the considerable variability in the kinetic parameters, the available data suggest that the rates of activation and deactivation of CF-I'R in oocytes are dominated by processes that are much slower than those which govern the durations of bursts and interburst intervals in the activated steady state. The sensitivity of activation and deactivation to NBF mutations implies that the binding and hydrolysis of ATP are important elements in these slow processes. As regards kinetic states, the slow processes could represent a long-lived closed state that precedes the bursting state, so that activation and deactivation rates would reflect transitions into and out of the bursting state. Alternatively, the slow processes could represent the progression through a series of closed states, each of which is connected to an open state that is more accessible or more stable than the one preceding.
Some support for the notion of a time-dependent change in burst kinetics can be found in the observations of Fischer and Machen (1994) , who studied the time course for activation of wild-type CFTR channels in NIH 3T3 fibroblasts after exposure to forskolin. They found that the open probability increased with a time constant of ~1 min, similar to that observed for the macroscopic conductance in oocytes. The increase in Po was primarily due to a decrease in the duration of a long closed state over this period. Preliminary observations suggest that a similar process occurs in oocytes; that is, after exposure to forskolin and IBMX, open times increase and interburst intervals decrease with a time course of minutes.
A minimal model for CFTR activation requires phosphorylation of one or more sites on the R domain and the binding and hydrolysis of ATP at one or both of the nucleotide binding folds. The apparent slow step in CFTR activation could reflect dynamics of changes that are initiated by the interaction of the phosphorylated R domain and the NBFs. Other studies have suggested that different phosphorylation states of CFTR have different gating properties. Hwang et al. (1993) , for example, defined two different phosphorylation states of CFFR, based on sensitivity to phosphatase inhibitors, and suggested that these two states exhibited differential sensitivity to ATP. Fischer and Machen (1994) also identified high and low Po states of CFTR that were associated with different levels of stimulation by forskolin. Also, a number of studies (Chang et al., 1993; Rich et al., 1993) have indicated that graded differences in CFTR channel activity can be achieved by the deletion of phosphorylation sites in the R domain or by the permanent deposition of negative charge at these sites. The kinetics of CFFR activation in oocytes may reflect the time dependence of conformational changes that depend on the phosphorylation state of the R domain, which could act to control the gain of ATP-dependent gating processes. The slow kinetics might also reflect the dme course of the addition and removal of CFTR channels from the plasma membrane.
Implications for Cystic Fibrosis
The results presented here provide some additional insights into the mechanism by which CFTR mutations produce disease. The conserved glycines in NBF1 (G551) and NBF2 (G1349) are both sites of mutations that cause either mild (G551S) or severe (G551D, G1349D) cystic fibrosis (Smitet al., 1993) but have not been associated with protein processing defects such as those that characterize the AF508 mutation. The analysis of activation kinetics presented here strengthens the notion that defects in channel function can cause cystic fibrosis and indicates that the molecular basis for defective function can lie both in the access to and the stability of the activated state. The activation of these mutants, however, suggests that understanding the details of these mechanisms could provide the basis for the design of pharmacologic therapies aimed at amelioration of the symptoms of cystic fibrosis.
